|The requirements for data disclosure in clinical trials are continuously evolving. Although the purpose is to ultimately make data transparency greater, the constant updates can make it hard to understand what the current regulations are and what are coming up. This leads to many questions, including what data submissions are requirement for certain trials? What are the implications of the new EU regulation and the US expanded rulemaking? How do these regulations impact the running of future clinical trials?
Watch this 30-minute on-demand webinar to:
|[contact-form-7 id=”10062″ title=”Contact form for webinar”]|